Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Caffeine enhances osteoclast differentiation and maturation through p38 MAP kinase/Mitf and DC-STAMP/CtsK and TRAP pathway.

Choi J, Choi SY, Lee SY, Lee JY, Kim HS, Lee SY, Lee NK.

Cell Signal. 2013 May;25(5):1222-7. doi: 10.1016/j.cellsig.2013.02.015. Epub 2013 Feb 19.

PMID:
23434822
2.

Ampelopsis brevipedunculata extract prevents bone loss by inhibiting osteoclastogenesis in vitro and in vivo.

Kim JY, Park SH, Oh HM, Kwak SC, Baek JM, Lee MS, Rho MC, Oh J.

Molecules. 2014 Nov 12;19(11):18465-78. doi: 10.3390/molecules191118465.

3.

Enhancement of RANKL-induced MITF-E expression and osteoclastogenesis by TGF-β.

Asai K, Funaba M, Murakami M.

Cell Biochem Funct. 2014 Jul;32(5):401-9. doi: 10.1002/cbf.3028. Epub 2014 Feb 12.

PMID:
24519885
4.

MITF and PU.1 recruit p38 MAPK and NFATc1 to target genes during osteoclast differentiation.

Sharma SM, Bronisz A, Hu R, Patel K, Mansky KC, Sif S, Ostrowski MC.

J Biol Chem. 2007 May 25;282(21):15921-9. Epub 2007 Apr 2.

5.

The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis.

Miyauchi Y, Ninomiya K, Miyamoto H, Sakamoto A, Iwasaki R, Hoshi H, Miyamoto K, Hao W, Yoshida S, Morioka H, Chiba K, Kato S, Tokuhisa T, Saitou M, Toyama Y, Suda T, Miyamoto T.

J Exp Med. 2010 Apr 12;207(4):751-62. doi: 10.1084/jem.20091957. Epub 2010 Apr 5.

6.

P38 mitogen-activated protein kinase inhibitor, FR167653, inhibits parathyroid hormone related protein-induced osteoclastogenesis and bone resorption.

Tao H, Okamoto M, Nishikawa M, Yoshikawa H, Myoui A.

PLoS One. 2011;6(8):e23199. doi: 10.1371/journal.pone.0023199. Epub 2011 Aug 23.

7.

Sexual Dimorphism in MAPK-Activated Protein Kinase-2 (MK2) Regulation of RANKL-Induced Osteoclastogenesis in Osteoclast Progenitor Subpopulations.

Herbert BA, Valerio MS, Gaestel M, Kirkwood KL.

PLoS One. 2015 May 6;10(5):e0125387. doi: 10.1371/journal.pone.0125387. eCollection 2015.

8.

Osteoclast stimulatory transmembrane protein (OC-STAMP), a novel protein induced by RANKL that promotes osteoclast differentiation.

Yang M, Birnbaum MJ, MacKay CA, Mason-Savas A, Thompson B, Odgren PR.

J Cell Physiol. 2008 May;215(2):497-505.

9.

The multifunctional protein fused in sarcoma (FUS) is a coactivator of microphthalmia-associated transcription factor (MITF).

Bronisz A, Carey HA, Godlewski J, Sif S, Ostrowski MC, Sharma SM.

J Biol Chem. 2014 Jan 3;289(1):326-34. doi: 10.1074/jbc.M113.493874. Epub 2013 Nov 20.

10.

Gymnasterkoreayne F inhibits osteoclast formation by suppressing NFATc1 and DC-STAMP expression.

Kim HJ, Hong J, Jung JW, Kim TH, Kim JA, Kim YH, Kim SY.

Int Immunopharmacol. 2010 Nov;10(11):1440-7. doi: 10.1016/j.intimp.2010.08.017. Epub 2010 Sep 8.

PMID:
20831919
11.

Coenzyme q10 regulates osteoclast and osteoblast differentiation.

Moon HJ, Ko WK, Jung MS, Kim JH, Lee WJ, Park KS, Heo JK, Bang JB, Kwon IK.

J Food Sci. 2013 May;78(5):H785-891. doi: 10.1111/1750-3841.12116. Epub 2013 Apr 12.

PMID:
23582186
12.

Immunoregulatory cytokines in mouse placental extracts inhibit in vitro osteoclast differentiation of murine macrophages.

Canellada A, Custidiano A, Abraham F, Rey E, Gentile T.

Placenta. 2013 Mar;34(3):231-9. doi: 10.1016/j.placenta.2012.12.015. Epub 2013 Jan 21.

PMID:
23347887
13.

Norisoboldine suppresses osteoclast differentiation through preventing the accumulation of TRAF6-TAK1 complexes and activation of MAPKs/NF-κB/c-Fos/NFATc1 Pathways.

Wei ZF, Tong B, Xia YF, Lu Q, Chou GX, Wang ZT, Dai Y.

PLoS One. 2013;8(3):e59171. doi: 10.1371/journal.pone.0059171. Epub 2013 Mar 11.

14.

Scoparone attenuates RANKL-induced osteoclastic differentiation through controlling reactive oxygen species production and scavenging.

Lee SH, Jang HD.

Exp Cell Res. 2015 Feb 15;331(2):267-77. doi: 10.1016/j.yexcr.2014.12.018. Epub 2015 Jan 6.

PMID:
25576385
15.

Agelasine D suppresses RANKL-induced osteoclastogenesis via down-regulation of c-Fos, NFATc1 and NF-κB.

Kang MR, Jo SA, Yoon YD, Park KH, Oh SJ, Yun J, Lee CW, Nam KH, Kim Y, Han SB, Yu J, Rho J, Kang JS.

Mar Drugs. 2014 Nov 24;12(11):5643-56. doi: 10.3390/md12115643.

16.

NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP).

Kim K, Lee SH, Ha Kim J, Choi Y, Kim N.

Mol Endocrinol. 2008 Jan;22(1):176-85. Epub 2007 Sep 20.

17.

Oral malodorous compound induces osteoclast differentiation without receptor activator of nuclear factor κB ligand.

Ii H, Imai T, Yaegaki K, Irie K, Ekuni D, Morita M.

J Periodontol. 2010 Nov;81(11):1691-7. doi: 10.1902/jop.2010.100116. Epub 2010 Jun 28.

PMID:
20583917
19.

Yukmijihwang-tang inhibits receptor activator for nuclear Factor-κB ligand-induced osteoclast differentiation.

Shim KS, Ma CJ, Kim DS, Ma JY.

J Med Food. 2011 Nov;14(11):1439-47. doi: 10.1089/jmf.2010.1502. Epub 2011 Sep 1.

PMID:
21883017
20.

Eos, MITF, and PU.1 recruit corepressors to osteoclast-specific genes in committed myeloid progenitors.

Hu R, Sharma SM, Bronisz A, Srinivasan R, Sankar U, Ostrowski MC.

Mol Cell Biol. 2007 Jun;27(11):4018-27. Epub 2007 Apr 2.

Supplemental Content

Support Center